中國建材(03323.HK):曹江林辭任公司董事長
格隆匯10月21日丨中國建材(03323.HK)公佈,公司董事會於2021年10月21日收到曹江林先生的辭職函。因工作調動,曹先生申請辭去公司董事長、執行董事的職務。曹先生的辭職於2021年10月21日起生效。因此,曹先生亦不再擔任公司戰略決策委員會主席、提名委員會委員、薪酬與考核委員會委員及《香港聯合交易所有限公司證券上市規則》第3.05條項下的公司授權代表職務,自2021年10月21日起生效。
為保證董事會的正常運作,董事會已於2021年10月21日召開董事會審議通過授權公司執行董事常張利先生代理行使公司董事長職權及委任常張利先生為公司授權代表的議案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.